Otolaryngology

Otorhinolaryngology is one of the earliest-established disciplines at our hospital, with diagnostic and treatment capabilities at the leading level in the autonomous region, and is one of the autonomous region’s clinical, research, and teaching centers for otorhinolaryngology. Currently, the department has 87 beds and 76 medical, nursing, and technical staff. Among the medical team are 3 Grade III chief physicians, 6 chief physicians or professors, 6 supervisors of master’s students, 5 associate chief physicians or associate professors, and 5 attending physicians; 1 Grade IV chief nurse, 4 associate chief nurses, and 3 nurses-in-charge; the discipline’s talent team includes 8 doctoral degree holders, 11 master’s degree holders, and 1 master’s student currently enrolled. This has formed a highly qualified medical and research team. The annual outpatient volume is nearly 80,000 visits, the annual average number of inpatients is more than 3,200, and the annual surgical volume is nearly 3,000 procedures; Grade III and IV surgeries account for 40% of the total annual surgical volume. The hospital attaches great importance to the department’s development and has provided matching funds of nearly 16 million yuan to support the construction and development of the discipline; while continually improving the facilities, it encourages department personnel to pursue degrees and undertake further study and training, bringing the department into line with the highest level of domestic otolaryngology–head and neck surgery. On the basis of maintaining its traditional strengths, the discipline actively develops new technologies and services. As a designated hospital in the autonomous region for cochlear implantation, it continuously explores the use of new types of artificial auditory ossicles and middle-ear implants while performing cochlear implantation surgery, with the aim of improving hearing restoration through middle-ear surgery. For head and neck malignancies, especially in patients with intermediate- and advanced-stage disease, induction chemotherapy and comprehensive treatment are actively provided, the quality of surgical reconstruction is improved, and the cure rate and quality of life of patients with head and neck malignancies are enhanced; transnasal skull-base, nasal–ocular-related, and lateral skull-base surgeries are actively performed.